Quarterly report · Q3

Period2023-06-01 → 2024-02-29
Filed2024-04-15
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥3.7bn2023-06-01 → 2024-02-29Cons.Net sales
Revenue¥4.5bn2022-06-01 → 2023-05-31Cons.Net sales (5-year summary)
Revenue¥3.1bn2022-06-01 → 2023-02-28Cons.Net sales
Operating income¥232m2023-06-01 → 2024-02-29Cons.Operating income
Operating income¥260m2022-06-01 → 2023-02-28Cons.Operating income
Ordinary income¥252m2023-06-01 → 2024-02-29Cons.Ordinary income
Ordinary income¥432m2022-06-01 → 2023-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥286m2022-06-01 → 2023-02-28Cons.Ordinary income
Profit before tax¥159m2023-06-01 → 2024-02-29Cons.Income before income taxes
Profit before tax¥248m2022-06-01 → 2023-02-28Cons.Income before income taxes
Net income (owners)¥46m2023-06-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income (owners)¥116m2022-06-01 → 2023-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥139m2022-06-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income¥62m2023-06-01 → 2024-02-29Cons.Profit loss
Net income¥153m2022-06-01 → 2023-02-28Cons.Profit loss
Total assets¥3.7bnat 2024-02-29Cons.Assets
Total assets¥3.5bnat 2023-05-31Cons.Assets
Total assets¥3.3bnat 2023-02-28Cons.Total assets (5-year summary)
Total liabilities¥1.7bnat 2024-02-29Cons.Liabilities
Total liabilities¥1.5bnat 2023-05-31Cons.Liabilities
Net assets / equity¥2.0bnat 2024-02-29Cons.Net assets
Net assets / equity¥1.9bnat 2023-05-31Cons.Net assets
Net assets / equity¥2.0bnat 2023-02-28Cons.Net assets (5-year summary)
Cash and deposits¥1.4bnat 2024-02-29Cons.Cash and deposits
Cash and deposits¥1.5bnat 2023-05-31Cons.Cash and deposits
EPS (basic)¥5.132023-06-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-7.672023-12-01 → 2024-02-29dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥12.972022-06-01 → 2023-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥15.612022-06-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥0.952022-12-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
Equity ratio53.0%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio55.3%at 2023-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio58.4%at 2023-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-06-01 → 2024-02-29¥10m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-06-01 → 2024-02-29¥10m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-06-01 → 2024-02-29−¥28m
jpcrp040300-q3r_E24982-000Mediaplatformreportable segmentrevenue2023-06-01 → 2024-02-29¥837m
jpcrp040300-q3r_E24982-000Mediaplatformreportable segmentrevenue external2023-06-01 → 2024-02-29¥837m
jpcrp040300-q3r_E24982-000Mediaplatformreportable segmentsegment profit2023-06-01 → 2024-02-29¥468m
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentrevenue2023-06-01 → 2024-02-29¥104m
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentrevenue external2023-06-01 → 2024-02-29¥104m
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentrevenue intersegment2023-06-01 → 2024-02-29¥9,000
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentsegment profit2023-06-01 → 2024-02-29¥5m
jpcrp040300-q3r_E24982-000Medical Institution Management Supportreportable segmentrevenue2023-06-01 → 2024-02-29¥2.7bn
jpcrp040300-q3r_E24982-000Medical Institution Management Supportreportable segmentrevenue external2023-06-01 → 2024-02-29¥2.7bn
jpcrp040300-q3r_E24982-000Medical Institution Management Supportreportable segmentsegment profit2023-06-01 → 2024-02-29¥115m
—segment totalrevenue2023-06-01 → 2024-02-29¥3.6bn
—segment totalrevenue external2023-06-01 → 2024-02-29¥3.6bn
—segment totalrevenue intersegment2023-06-01 → 2024-02-29¥9,000
—segment totalsegment profit2023-06-01 → 2024-02-29¥588m
Total Of Reportable Segments And Otherssegment totalrevenue2023-06-01 → 2024-02-29¥3.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-06-01 → 2024-02-29¥3.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-06-01 → 2024-02-29¥9,000
Total Of Reportable Segments And Otherssegment totalsegment profit2023-06-01 → 2024-02-29¥560m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-06-01 → 2023-02-28¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-06-01 → 2023-02-28¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-06-01 → 2023-02-28¥3m
jpcrp040300-q3r_E24982-000Mediaplatformreportable segmentrevenue2022-06-01 → 2023-02-28¥769m
jpcrp040300-q3r_E24982-000Mediaplatformreportable segmentrevenue external2022-06-01 → 2023-02-28¥769m
jpcrp040300-q3r_E24982-000Mediaplatformreportable segmentrevenue intersegment2022-06-01 → 2023-02-28¥2,000
jpcrp040300-q3r_E24982-000Mediaplatformreportable segmentsegment profit2022-06-01 → 2023-02-28¥461m
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentrevenue2022-06-01 → 2023-02-28¥117m
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentrevenue external2022-06-01 → 2023-02-28¥117m
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentrevenue intersegment2022-06-01 → 2023-02-28¥17,000
jpcrp040300-q3r_E24982-000Medical B To Breportable segmentsegment profit2022-06-01 → 2023-02-28¥29m
jpcrp040300-q3r_E24982-000Medical Institution Management Supportreportable segmentrevenue2022-06-01 → 2023-02-28¥2.2bn
jpcrp040300-q3r_E24982-000Medical Institution Management Supportreportable segmentrevenue external2022-06-01 → 2023-02-28¥2.2bn
jpcrp040300-q3r_E24982-000Medical Institution Management Supportreportable segmentrevenue intersegment2022-06-01 → 2023-02-28¥213,000
jpcrp040300-q3r_E24982-000Medical Institution Management Supportreportable segmentsegment profit2022-06-01 → 2023-02-28¥64m
—segment totalrevenue2022-06-01 → 2023-02-28¥3.1bn
—segment totalrevenue external2022-06-01 → 2023-02-28¥3.1bn
—segment totalrevenue intersegment2022-06-01 → 2023-02-28¥233,000
—segment totalsegment profit2022-06-01 → 2023-02-28¥554m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-02-28¥3.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-02-28¥3.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-06-01 → 2023-02-28¥233,000
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-02-28¥556m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 360
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)Mooreみらい監査法人
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)高砂 晋平
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)吉原 浩
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1YTDDuration3125576000JPY
Net sales (5-year summary)CurrentYTDDuration3655683000JPY
Net sales (5-year summary)Prior1YearDuration4500846000JPY
Ordinary income loss (5-year summary)Prior1YTDDuration285995000JPY
Ordinary income loss (5-year summary)CurrentYTDDuration251720000JPY
Ordinary income loss (5-year summary)Prior1YearDuration431749000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YTDDuration139457000JPY
Profit loss attributable to owners of parent (5-year summary)CurrentYTDDuration46413000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YearDuration116181000JPY
Comprehensive income (5-year summary)Prior1YTDDuration156256000JPY
Comprehensive income (5-year summary)CurrentYTDDuration62516000JPY
Comprehensive income (5-year summary)Prior1YearDuration114190000JPY
Net assets (5-year summary)Prior1QuarterInstant1971086000JPY
Net assets (5-year summary)CurrentQuarterInstant1966572000JPY
Net assets (5-year summary)Prior1YearInstant1929020000JPY
Total assets (5-year summary)Prior1QuarterInstant3309193000JPY
Total assets (5-year summary)CurrentQuarterInstant3669646000JPY
Total assets (5-year summary)Prior1YearInstant3467360000JPY
Basic earnings loss per share (5-year summary)Prior1YTDDuration15.61
Basic earnings loss per share (5-year summary)CurrentYTDDuration5.13
Basic earnings loss per share (5-year summary)Prior1YearDuration12.97
Diluted earnings per share (5-year summary)Prior1YTDDuration-
Diluted earnings per share (5-year summary)CurrentYTDDuration-
Diluted earnings per share (5-year summary)Prior1YearDuration-
Equity to asset ratio (5-year summary)Prior1QuarterInstant0.5843
Equity to asset ratio (5-year summary)CurrentQuarterInstant0.5298
Equity to asset ratio (5-year summary)Prior1YearInstant0.5529
Basic earnings loss per share (5-year summary)Prior1QuarterDuration0.95
Basic earnings loss per share (5-year summary)CurrentQuarterDuration-7.67
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember10773000
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember10773000
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant10773000
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant10773000
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember1727700
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember9038400
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember90384
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember6900
Number of shares issued shares voting rightsCurrentQuarterInstant10773000
Number of voting rights issued shares voting rightsCurrentQuarterInstant90384
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member1727700
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-05-31pass
balance sheet identityconsolidated 2024-02-29pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-05-31pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-06-01/2024-02-29pass
statement vs summary · revenueconsolidated 2022-06-01/2023-02-28pass
statement vs summary · revenueconsolidated 2023-06-01/2024-02-29pass
statement vs summary · total assetsconsolidated 2023-05-31pass
statement vs summary · total assetsconsolidated 2024-02-29pass